Global Experts Meeting on

Reproductive Biology and Endocrinology

Tokyo, Japan   May 07-08, 2018

Reproductive Endocrinology Meeting-2018

Tokyo, Japan May 07-08, 2018

Theme: Innovative Outcomes in Reproductive Biology and Endocrinology

Meetings International is pleased to announce the Global Experts Meeting on Reproductive Biology and Endocrinology scheduled during May 07- 08, 2018 in Tokyo, Japan with a theme "Innovative Outcomes  in Reproductive Biology and Endocrinology"

Meeting International welcomes you to the ‘Global Expert Meeting on Reproductive Biology and Endocrinology’ to be held from May 07-08, 2018 in Tokyo, Japan. Meeting International organizes 1000+ Global events inclusive of 300+ International Conferences  every year across  the globe.

Reproductive Biology and Endocrinology includes topics such as the pathophysiology of reproduction (e.g. sterility, infertility and abnormal pregnancy, and reproductive tract infections), age-associated changes and disorders of the reproductive tract, reproductive tissue cancers (e.g. prostate, ovary, uterus, cervix, breast), and the impact of environmental and occupational hazards on reproduction. where as Endocrinology is the study of the endocrine system in the human body. This is a system of glands which secrete hormones. Hormones are chemicals which affect the actions of different organ systems in the body. Examples include thyroid hormone, growth hormone, insulin and sex hormones.

Target Audience:

  • Gynaecologists 
  •  Reproductive Epidemiologists
  •  Reproductive and developmental biologists
  •  Infertility specialists
  •  Reproductive Endocrinologists
  •  Specialists in menopause
  •  Reproductive tract oncologists
  •  Doctors, Nurses, Healthcare Professionals
  •  Andrologists
  •  Endocrinologists
  •  Pharmacologists, obstetricians and Clinicians
  •  Directors of Association and Societies
  •  Urogynecologists
  •  Postgraduate students
  •  Industries which produce devices ( reproductive and endocrinology devices)
  •  Young Researchers and scientists
  •  Professors and Assistant Professors
  •  Midwife and those who work in research and development of pharmaceuticals and related technology.

Why to attend:

  •   Learn new ideas for serving clients
  •   Engage your mind and enrich your heart with new insights
  •   Discover how advances in the health sector are impacting globally
  •   Share experiences, insights and strategies in interactive peer-to peer round tables
  •   Global networking: In transferring and exchanging Ideas.
  •   Stay abreast the latest required skills and knowledge

Track1: Reproductive Biology

Reproductive Biology is a science which deals with the propagation in people, creatures and plants at the atomic, cellular, tissue and life form stages. Improved understanding of reproductive biology can lead to new treatments for reproductive disorders, such as infertility. Researcher in this field search for the answers of fruitlessness and try to hold fundamental hereditary qualities, especially in jeopardized species. Numerous regenerative science programs incorporate investigations of the bosom, colon, and endometrial malignancies, and in addition endometriosis. Reproductive Endocrinology is claiming to fame of Obstetrics and Gynecology. Reproductive biology aims to understand the scientific principles that govern reproduction in humans and other mammals. Reproductive Biology and Endocrinology additionally covers clinical subjects, for example, the pathophysiology of proliferation, age-related changes and scatters of the regenerative tract (e.g. peri-and postmenopausal periods, urinary incontinence and other pelvic floor issue, effect of hormone substitution treatment), conceptive tissue malignancies (e.g. prostate, ovary, uterus, cervix, bosom), and the effect of ecological and word related dangers on generation.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 2: Reproductive Immunology

Reproductive immunology refers to the study of interactions (or the absence of them) between the immune system and components related to the reproductive system, such as maternal immune tolerance towards the fetus, or immunological interactions across the blood-testis barrier. The concept has been used by fertility clinics to explain the fertility problems, recurrent miscarriages and pregnancy complications observed when this state of immunological tolerance is not successfully achieved. Immunological therapy is the new up and coming method for treating many cases of previously "unexplained infertility" or recurrent miscarriage.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 3: Reproductive Physiology

Reproductive Physiology incorporates both male conceptive physiology and female regenerative physiology. Male conceptive framework partitioned into two gatherings i.e. Primary organs, Accessory organs while Primary Organs incorporate Gonads or Sex organs, create germ cell and make Hormones, Male gonad is Testis. Whereas Accessory organs incorporate arrangement of pipes that vehicle the germ cells and different exocrine organs. Female conceptive Physiology incorporates Female gonads are the ovaries where the sex cells or ova are shaped. Rest of Female conceptive tract comprises of uterus to hold creating new-born child, different section ways, outside genital organs. Embellishment organs incorporate oviducts, uterus, vagina, more noteworthy vestibular organs, vulva, and perineum

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 4: Reproductive Technology

 Reproductive Technology connected to the adjustment of generation in people and different creatures; particularly (more completely "helped conceptive innovation") such innovation utilized for the treatment of fruitlessness, regularly including the control of eggs, sperm, and developing lives.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 5: Reproductive Health Commodity Security

Reproductive health commodity security (RHCS) exists when each individual can pick, acquire, and utilize quality contraceptives and other basic regenerative wellbeing items at whatever point they require them. The capacity to choose underlines the significance of giving the customer the data they have to settle on an educated decision. It is predicated on a scope of family arranging strategies being accessible, and in addition precise data and a nonattendance of supplier predisposition. inadequately planned exercises among key partners, frail or insufficient coordination’s frameworks, arrangement hindrances to customer get to.

Related Conferences:

Annual Summit n Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 6: Pregnancy and Pregnancy Complication

Pregnancy is commonly secluded into three trimesters. The chief trimester is from week one through 12 and joins begin. Begin is the time when the sperm prepares the egg. The second trimester is from week 13 through 28. Around the point of convergence of the second trimester, change of the youngster might be felt. At 28 weeks, more than 90% of youths can make due outside of the uterus if gave astounding remedial care. The third trimester is from 29 weeks through 40 weeks

Complications can emerge in pregnancies for some reasons. Here and there ladies' current wellbeing conditions can add to issues and different circumstances new conditions emerge in view of body and hormonal changes that happen amid pregnancy. Each pregnancy has its dangers. At the point when certain medicinal conditions emerge before or amid pregnancy, more watchful checking is required. Pregnancies are named "high hazard" when there are confusions with either the mother or the child that need cautious checking and perception. The greater part of our suppliers has the ability and assets accessible to oversee high hazard pregnancies. A high hazard pregnancy requires a group approach.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 7: Menopause and Infertility

At the point when a lady enters menopause, which is motioned by nonappearance of menses for 12 months, her eggs are exhausted and she is barren. Menopause is a characteristic procedure that by and large occurs in a lady's 40s or 50s, with the normal time of menopause in the U.S. being 51 Most ladies lose their fruitfulness in their mid-40s, preceding menopause because of impacts of maturing on the amount and nature of Most ladies lose their ripeness in their mid-40s, preceding menopause because of impacts of maturing on the amount and nature of eggs  .Menopause is a characteristic procedure that by and large occurs in a lady's 40s or 50s, with the Menopause is the finish of a lady's menstrual cycle and denote the finish of her ripeness. 

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 8: Sexually Transmitted Infections/Diseases

Sexually Transmitted Infections (STIs), otherwise called Sexually Transmitted Diseases (STDs) or Venereal Diseases (VD) are illnesses that are passed on starting with one individual then onto the next through sexual contact, and here and there by genital contact - the contamination can be passed on by means of vaginal intercourse, oral sex, and butt-centric sex. Some sexually transmitted contaminations can spread using unsterilized IV sedate needles, from mother to infant amid labor or breastfeeding, and blood transfusions. Sexually transmitted contaminations have been around for a huge number of years.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 9. Endocrinology

Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases and its specific secretions known as hormones, growth promotion and malignancyBehavioral endocrinology is the study of hormonal processes and neuroendocrine systems that influence or regulate behavior. Endocrinology includes the wide area that not only affects our endocrine system, but also has effects on skin which shows indirectly involvement of dermatology.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 10. Reproductive Endocrinology and Infertility

Reproductive endocrinology and infertility is a surgical subspecialty of obstetrics and gynecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction as well as the issue of infertility. While most Reproductive endocrinology and infertility specialists primarily focus on the treatment of infertility, reproductive endocrinologists are trained to also evaluate and treat hormonal dysfunctions in females and males outside infertility. Reproductive endocrinologists have specialty training in obstetrics and gynecology (ob-gyn) before they undergo sub-specialty training (fellowship) in Reproductive endocrinology and infertility.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 11: Sex Hormone Disorders

Sex hormone disorders occur when there is either an overproduction or underproduction of the hormones responsible for sexual characteristics and development. In females, the main female hormone is estrogen which is primarily produced by the ovaries. Women also produce androgens. Testosterone and DHEAS are two of the androgens women produce. When these hormones are not in balance women may experience symptoms including menstrual cycle irregularities, hirsutism, acne and alopecia. In males, the main male hormone is testosterone. When males do not produce enough testosterone, they may experience a decline in libido, erectile dysfunction, loss of muscle and loss of body hair.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

 Track 12: Reproductive Health 

Reproductive health refers to the illnesses, disorders and conditions that influence the working of the male and female regenerative frameworks amid all phases of life. Reproductive health as a condition of entire physical, mental and group prosperity, regenerative wellbeing talks the conceptive advancements, capacities and framework at all periods of life. Reproductive health, consequently, recommends that individuals can have an obligated, fulfilling and more secure sexual co-existence and that they can repeat and the freedom to pick if, when and how regularly to do as such. One elucidation of this proposes men and ladies ought to be educated of and to have contact to protected, powerful, sensible and adequate strategies for anti-conception medication; in addition, contact to fitting social insurance offices of sexual, regenerative prescription and utilization of wellbeing preparing projects to weight the significance of ladies to go securely through pregnancy and labor could offer couples with the most obvious opportunity with regards to having a sound child. Then again, people do confront varieties in regenerative wellbeing administrations.

Related Conferences:

Annual Summit n Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 13.  Clinical and Reproductive Endocrinology

Clinical and reproductive endocrinology is the study of the endocrine system, its function, and its diseases or abnormalities as related to patient care. In other words, a clinical endocrinologist would spend most of his/her time seeing patients who have one or more disorders of the endocrine system. The endocrine system can be defined as those organs in the body which release hormones that regulate many of the body’s functions, like the testes and ovaries, the pancreas, the pituitary gland, and the thyroid gland. Those who specialize in clinical endocrinology are highly trained physicians. Additional conditions, on which clinical and reproductive endocrinology concentrates, include thyroid disorders, which may have significant effect on all body functions when ignored. Hormone disorders of other types can be treated by endocrinologists. Problems with estrogen of progesterone production in the female body could cause many symptoms like reduced fertility.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 14: Reproductive Toxicology

Reproductive Toxicology is the impact of substance and physical specialists on proliferation. It for the most part includes logical introductions from obstetricians, paediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others keen on distinguishing potential regenerative risks. All parts of proliferation are inside extent of Reproductive Toxicology, including arrangement and development of regenerative gametes, sexual capacity, occasions encompassing combination of gametes and the improvement of prepared ovum, food and transport of concept us inside genital tract, implantation, embryogenesis, intrauterine development, placentation and placental capacity, parturition, lactation and neonatal survival. Adverse reproductive effects in males are as significant as adverse effects occurring in females. Typical end-point studies include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 15: Reproductive Functional Disorders 

Reproductive Functional disorders refers to the disorders due to deformation or degeneration of reproductive organs. Many other reproductive functional disorders have also been link to exposure to synthetic and environmental chemicals. Common chemicals with known links to reproductive disorders include: lead, dioxins and dioxin-like compounds, styrene, toluene, BPA (Bisphenol A) and pesticides.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Track 16: Reproductive and Endocrine Cancers 

Cancers are a large family of diseases that involve abnormal cell growth with the potential to invade or spread to other parts of the body. They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth and will often form a mass or lump, but may be distributed diffusely. usually the most prone systems are reproductive and endocrine systems.  Some hormones play a role in the development of cancer by promoting cell proliferation. Hormones are important agents in sex-related cancers, such as cancer of the breast, endometrium, prostate, ovary, testis, thyroid cancer and bone cancer.

Related Conferences:

Annual Summit on Sexual and Reproductive Health October 2-3, 2017,  Atlanta, Georgia, USA;  ICCRHC 2017 : 19th International Conference on Contraception and Reproductive Health Care  January 12-13, 2017, Durban,  South Africa; ICAMPOS 2017: International Conference on Advanced Management of Polycystic Ovarian Syndrome  June 15-16, 2017,  Toronto; ICAWH 2017: International Conference on Abortions and Women’s Health September 28-29, 2017, Istanbul; BFPA's Sexual & Reproductive Health Conference June 24-25, 2017,  Bridgetown, Barbados; Women’s Health 2017- International Women’s Health ,Gynaecology and Obstetrics Conference November 16-18, 2017, Dubai, United Arab Emirates; The 25th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI)  November 30 -2 December, 2017, Vienna, AUSTRIA.

Scope and Importance:

Reproductive - Endocrinology meeting 2018 provides a worldwide stage to worldwide systems administration and trading most recent developments in reproductive biology and endocrinology. Reproductive biology includes both sexual and asexual reproduction. Reproductive biology includes a wide number of fields Reproductive systems, Endocrinology, Sexual development, Sexual development, Reproduction, Fertility. Human reproductive biology is mainly controlled through hormones, which send signals to the human reproductive structures to influence growth and maturation. These hormones are secreted by endocrine glands, and spread to different tissues in the human body.

In humans, the pituitary gland synthesizes hormones used to control the activity of endocrine glands and metabolic Disorders like Adrenal Disorders, Pituitary Disorders, Diabetes and Related Complications, Diseases and Disorders of the Thyroid, Thyroid Nodules and Tumors, Gynecomastia, Lipid Disorders, Osteoporosis, Parathyroid and Calcium Disorders.  Proven rehearsals request alters in the enlightenment of novice, more practice-relevant research, and closer working relationships between clinicians and researchers. An evidence-based practice also provides opportunities for endocrinologists to be more analyzed, more efficacious, well-organized, and spirited, and to exaggerate effects of the clinical judgment.

Meetings International put together the entire eminent reproductive biologists and endocrinologist across the globe to share their knowledge and views on the respective conference theme.

 Why to Attend?

As the leading event in its niche field of ultrasound in reproductive biology and endocrinology, we were delighted to welcome international experts from all corners of the world to present cutting edge scientific breakthroughs, offer clinical guidance and participate in lively discussions on sub-specialist areas.

Unique opportunity to discuss case studies and meet some of the most influential professionals in reproductive biology and endocrinology. The program is presented through a variety of sessions including seminal plenary lectures and didactic workshops where international experts are invited to deliver lively discussion sessions on sub-speciality topics. Cutting-edge research updates comprise more than 50% of the program and are delivered through the oral communication, short oral and poster sessions.

Who can attend?

Individuals around the globe concentrated on finding out about the reproductive biology and endocrinology Practice and its advances; this is a good opportunity to go to attend the Conference and achieve the biggest collection of members from the Medical Health sector. 

Why Japan? 

Japan is the 3rd largest economy in the world. It has a GDP 1.5 the size of UK and per capita GDP 6 times that of China; Japan remains the high-tech powerhouse economy of Asia. It is the second highest spending worldwide on R&D, Japanese companies remain amongst the most technologically valuable and advanced in the world. Japan’s major growth driver is exports despite external demand accounting for 16% of its total GDP.

Target Audience:

DEAN, Doctors, Research associates, Professors, assistant professors, associate professors, head of the departments, CEO of companies, related societies members, related association members and Students from Academia in the study reproductive biology and endocrinology fields.

Market Research on Reproductive Biology and Endocrinology:

Commissioned by a market leader in human reproductive Health and endocrine disorders, this report uniquely provides a comprehensive analysis of current and pipeline about reproductive endocrinology, which is not available elsewhere in the market literature; Provides a concise overview of the conditions and diseases related to reproductive endocrinology including aetiology, epidemiology, and management.  Since the incidence rate of reproductive disorders are exceptionally high across the world, fueled by an unhealthy diet and reduced individual hygiene, the global market is likely to remain to experience a high-paced rise in the years to come. The reproductive-endocrinology drugs market in the japan is expected to reach 20% higher than the present value by 2020, growing at a CAGR of over 6%.

Due to the high prevalence of reproductive- endocrine disorders, the demand for drugs is higher than other products. Researchers expect this trend to remain so over the next few years, resulting in the high growth rate of the reproductive and endocrine drug segment. The introduction of novel drug therapies and the presence of robust product pipelines in this market are likely to add significantly to the rise of this segment in the yearsto come

List of Universites in Japan

  • Tohoku University
  • University of Tokyo
  • Kyoto University 
  • Nagoya university
  • Tokyo Institute of Technology
  • Osaka University
  • Kyushu University
  • Hokkaido University
  • University of Tsukuba
  • Waseda University   

Universities in Worldwide:

  •  Harvard University
  •  University of Oxford
  •  Stanford University
  •  University of Cambridge
  •  Princeton University
  •  University of California, Berkeley
  •  Imperial College London
  •  Yale University
  •  ETH Zürich – Swiss Federal Institute of Technology Zurich
  •  University of Toronto
  •  University of Tokyo
  •  University of Melbourne
  •  University of British Columbia

  • Reproductive Biology
  • Reproductive Immunology
  • Reproductive Physiology
  • Reproductive Technology
  • Reproductive Health Commodity Security
  • Pregnancy and Pregnancy Complication
  • Menopause and Infertility
  • Sexually Transmitted Infections/Diseases
  • Endocrinology
  • Reproductive Endocrinology and Infertility
  • Sex Hormone Disorders
  • Reproductive Health
  • Clinical and Reproductive Endocrinology
  • Reproductive Toxicology
  • Reproductive Functional Disorders
  • Reproductive and Endocrine Cancers